I now have comprehensive content from authoritative sources. Here is the full treatment guide:
Treatment of Diabetic Ketoacidosis (DKA)
DKA is managed with four simultaneous pillars: fluid resuscitation, insulin, electrolyte replacement, and identifying/treating the precipitant.
Diagnostic Workup First
Before or alongside treatment, obtain:
- Serum glucose, electrolytes, BUN/creatinine, serum ketones (beta-hydroxybutyrate preferred)
- ABG (or VBG)
- CBC with differential
- Urinalysis, urine/blood cultures if infection suspected
- ECG (to detect hyperkalemia changes or MI as precipitant)
- Chest X-ray if indicated
1. Fluid Resuscitation
Fluid deficit is typically 7-9% of body weight in adults.
| Phase | Fluid | Rate |
|---|
| Initial volume expansion | 0.9% Normal Saline | 1 L bolus, then 500-1000 mL/h |
| Ongoing repletion (normonatremic) | 0.45% Saline | 150-500 mL/h |
| Ongoing repletion (hyponatremic) | 0.9% Saline | 150-500 mL/h |
| When glucose falls to <250 mg/dL | Switch to D5W / 0.45% NS | Continue to prevent hypoglycemia |
- Aim for positive fluid balance over 12-24 hours
- Correct no faster than 3 mOsm/kg/h to reduce risk of osmotic encephalopathy
- In pediatric DKA: 20 mL/kg NS in the first hour
- Monitor BP and urine output to guide rate adjustments
2. Insulin
- Do NOT start insulin until potassium is ≥ 3.5 mEq/L (risk of fatal hypokalemia otherwise)
- Initial bolus: 0.1 units/kg regular insulin IV
- Continuous infusion: 0.1 units/kg/h regular insulin IV
- Standard preparation: 100 units regular insulin in 100 mL 0.9% saline (1 unit/mL)
- Target glucose reduction: 50-75 mg/dL/h (avoid >100 mg/dL/h to prevent osmotic encephalopathy)
- When glucose reaches <250 mg/dL: add dextrose and reduce insulin to 0.05 units/kg/h
- Continue insulin until: HCO3 >15 mEq/L, anion gap closed, and clinical improvement
- Before stopping infusion: give subcutaneous basal insulin 2 hours prior to discontinuing IV insulin to prevent rebound ketosis
- Two-bag approach (separate dextrose bag + saline bag) allows independent titration and has been shown to shorten treatment duration
3. Potassium
Insulin drives potassium into cells, causing dangerous hypokalemia.
| Serum K+ | Action |
|---|
| < 3.5 mEq/L | Hold insulin; replace K+ aggressively before starting |
| 3.5-5.5 mEq/L | Add 20-40 mEq KCl per liter of IV fluid |
| > 5.5 mEq/L | Hold K+ supplementation; monitor closely |
- Add at 10-20 mEq/h to fluids
- Place on telemetry due to risk of arrhythmias from K+ shifts
4. Bicarbonate
Bicarbonate is not routinely recommended - insulin and fluids correct the acidosis adequately.
Consider bicarbonate only if:
- pH < 6.9
- HCO3 < 5 mEq/L
- Hemodynamic instability / shock / coma
- Severe hyperkalemia with cardiac/respiratory dysfunction
If given: 50-100 mEq in 1 L of 0.45% saline over 30-60 min; add 10 mEq KCl to avoid hypokalemia.
5. Phosphate and Magnesium
- Phosphate: not routinely replaced; may give K-Phos IV if patient is not eating or levels critically low
- Magnesium: correct with 1-2 g MgSO4 IV; give 10-20 mEq MgSO4 IV for ventricular arrhythmias
6. Treat the Precipitant
Common triggers to identify and address:
- Infection (most common) - start empiric broad-spectrum antibiotics for sepsis or documented infection. Note: DKA itself does not cause fever, so fever means infection.
- Missed/insufficient insulin doses
- New-onset diabetes
- Myocardial infarction
- Medications (steroids, SGLT2 inhibitors)
- Pancreatitis, surgery, trauma
Monitoring During Treatment
| Parameter | Frequency |
|---|
| Blood glucose | Every hour |
| Electrolytes (Na, K, Cl, HCO3) | Every 2-4 hours |
| ABG / pH | As needed (more often if severe acidosis) |
| Beta-hydroxybutyrate | Serial measurements if available |
| Urine output | Continuous |
| Vital signs | Continuous |
Key monitoring points:
- Serum sodium should rise as hyperglycemia corrects; if it doesn't, suspect overhydration with free water
- Anion gap closure is a less reliable endpoint than serum bicarbonate normalization (hyperchloremia from NS can close the gap before true resolution)
- Beta-hydroxybutyrate normalization is the gold standard for resolution
Resolution Criteria (all three must be met)
- Blood glucose < 200-250 mg/dL
- HCO3 ≥ 15 mEq/L
- Anion gap closed (< 12 mEq/L)
Complications to Watch For
- Cerebral edema - most feared, especially in children; caused by too-rapid osmotic shifts
- Hypokalemia - from insulin therapy; potentially fatal arrhythmias
- Hypoglycemia - from excess insulin without dextrose
- Lactic acidosis - suspect if persistent anion gap despite treatment; manage with volume, control sepsis
- Arterial thrombosis (stroke, MI, limb ischemia) - increased frequency in DKA; anticoagulate only for specific thrombotic events
- Acute lung injury - rare
Special Considerations
Intubation: Avoid if possible. Patients in DKA have a strong respiratory drive (Kussmaul breathing as compensation); if intubated, matching minute ventilation is challenging. Intubate only for comatose patients or uncontrolled vomiting.
Euglycemic DKA (associated with SGLT2 inhibitors): glucose may be near-normal despite active ketoacidosis - diagnosis can be missed. Keep a high index of suspicion.
Admission criteria: Most patients require ICU or monitored bed. Outpatient treatment may be considered in children only if pH ≥ 7.35, HCO3 ≥ 20 mEq/L, tolerating oral fluids, and no precipitant requiring hospitalization.
Sources: The Washington Manual of Medical Therapeutics, p. 890-891; Rosen's Emergency Medicine, Box 115.1; Tintinalli's Emergency Medicine, p. 2267-2272
A 2024
systematic review (PMID 38154537) on emergency care interventions for DKA confirms that IV fluid resuscitation and insulin remain the cornerstones of treatment, consistent with the above guidelines.